Basic Information
ID: ALA711329
Type: Functional
Description: In vivo efficacy against Madison Murine lung carcinoma M109 tumors implanted ip and the drug given ip on days 5 and 8 post implantation.
Organism: Mus musculus
Cell type: M109
Activity Charts
Bioactivity
Activity Types for Assay ALA711329
Efficacy
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 914.01 | 4.09 | 4.09 |
| 853.92 | 3.74 | 3.74 |
| 898.02 | 5.11 | 5.11 |
| 928.04 | 4.74 | 4.74 |
| 874.06 | 5.13 | 5.13 |
| 910.02 | 4.18 | 4.18 |
| 869.96 | 4.41 | 4.41 |
| 914.01 | 5.22 | 5.22 |
| 882.04 | 5.14 | 5.14 |
| 896.06 | 5.54 | 5.54 |
| 853.96 | 4.75 | 4.75 |
| 899.98 | 3.77 | 3.77 |
| 896.07 | 5.54 | 5.54 |
| 886.03 | 5.13 | 5.13 |
| 890.02 | 5.03 | 5.03 |
| 885.96 | 3.38 | 3.38 |
| 880.00 | 4.82 | 4.82 |
| 883.99 | 4.72 | 4.72 |
| 900.06 | 5.44 | 5.44 |